Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | RPRX | BNTX | ||
| Company | Biogen Inc | Royalty Pharma Plc Cl A | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 185.06 | 47.50 | 102.52 | ||
| High | 190.37 | 47.86 | 104.08 | ||
| Low | 183.16 | 47.25 | 99.82 | ||
| Latest | 189.94 | 47.43 | 103.80 | ||
| Change | +5.92 | -0.05 | +3.04 | ||
| % Change | +3.22% | -0.11% | +3.02% | ||
| Volume | 952,900 | 4,344,600 | 732,300 | ||
| 20-Day Average Volume | 1,370,675 | 3,888,550 | 622,300 | ||
| Previous Close | 184.02 | 47.48 | 100.76 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 191.80 | 45.29 | 107.92 | ||
| 20-Day Raw Stochastic | 50.73% | 91.98% | 42.56% | ||
| 20-Day Relative Strength | 53.77 | 77.38 | 45.70 | ||
| Weighted Alpha | +36.94 | +51.54 | -2.73 | ||
| Today's Opinion | 88% Buy | 100% Buy | 16% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | Hold | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.41% since 02/25/26 | +5.05% since 02/25/26 | -5.50% since 02/25/26 | ||
| Low | 181.79 on 03/03/26 | 44.88 on 02/26/26 | 97.22 on 03/03/26 | ||
| High | 192.46 on 02/27/26 | 47.86 on 03/04/26 | 111.05 on 02/27/26 | ||
| 1-Month | |||||
| %Chg | +2.42% since 02/04/26 | +8.59% since 02/04/26 | -4.57% since 02/04/26 | ||
| Low | 181.79 on 03/03/26 | 42.50 on 02/11/26 | 97.22 on 03/03/26 | ||
| High | 202.41 on 02/06/26 | 47.86 on 03/04/26 | 112.68 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +4.37% since 12/04/25 | +21.15% since 12/04/25 | +8.13% since 12/04/25 | ||
| Low | 160.36 on 01/20/26 | 37.83 on 12/16/25 | 91.11 on 12/18/25 | ||
| High | 202.41 on 02/06/26 | 47.86 on 03/04/26 | 124.00 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +35.73% since 09/04/25 | +28.54% since 09/04/25 | +0.29% since 09/04/25 | ||
| Low | 135.39 on 09/29/25 | 34.08 on 09/08/25 | 90.12 on 09/12/25 | ||
| High | 202.41 on 02/06/26 | 47.86 on 03/04/26 | 124.00 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,006,592 | 27,389,170 | 22,689,340 | ||
| Shares Outstanding, K | 146,759 | 576,857 | 225,182 | ||
| Annual Sales | 9,890,600,000 | 2,378,190,000 | 2,976,970,000 | ||
| Annual Net Income | 1,292,900,000 | 770,950,000 | -719,920,000 | ||
| Last Quarter Sales | 2,279,400,000 | 621,990,000 | 1,775,440,000 | ||
| Last Quarter Net Income | -48,900,000 | 214,210,000 | -33,550,000 | ||
| 60-Month Beta | 0.15 | 0.40 | 1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 02/06/26 | 1.17 on 11/05/25 | -0.14 on 11/03/25 | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 03/10/26 | ||
| Most Recent Dividend | N/A | 0.235 on 02/20/26 | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 12.30 | 9.83 | 0.00 | ||